Literature DB >> 6459011

The autologous mixed-lymphocyte reaction.

M E Weksler, C E Moody, R W Kozak.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6459011     DOI： 10.1016/s0065-2776(08)60923-2

Source DB:  PubMed          Journal:  Adv Immunol        ISSN： 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  38 in total

1.  An increase in number of T-cell receptor gamma/delta-bearing T cells in athymic nude mice treated with complete Freund's adjuvants.

Authors:  Y Yoshikai; G Matsuzaki; T Inoue; K Nomoto
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

2.  Severe T lymphocyte immunodeficiency associated with hypogammaglobulinemia: defective lymphokine secretion but enhanced autologous mixed lymphocyte reaction.

Authors:  S Raziuddin; B Teklu
Journal:  J Clin Immunol       Date:  1989-11       Impact factor: 8.317

Review 3.  Premises for immune interventional therapy in rheumatoid arthritis.

Authors:  I R Mackay; M J Rowley
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

4.  Abnormalities of T cells isolated from mediastinal lymph nodes and peripheral blood of patients with lung carcinoma: deficit in PHA-induced expression of HLA class II antigens and in autologous mixed lymphocyte reactions.

Authors:  F Indiveri; I Pierri; S Rogna; A Poggi; R Romano; A Tavano; G Ratto; G Motta; S Ferrone
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Activation of immune regulatory circuits among OKT4+ cells by autologous mixed lymphocyte reactions.

Authors:  H Kotani; S Takada; Y Ueda; Y Murakawa; N Suzuki; T Sakane
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

6.  Phorbol ester treated chronic B lymphocytic leukaemia cells induce autologous T cell proliferation without generation of cytotoxic T cells.

Authors:  D Kabelitz; T H Tötterman; K Nilsson; M Gidlund
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

7.  Treating activated CD4+ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice.

Authors:  J Quddus; K J Johnson; J Gavalchin; E P Amento; C E Chrisp; R L Yung; B C Richardson
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

8.  Autologous mixed lymphocyte reaction in man: XV. Cellular and molecular basis of deficient autologous mixed lymphocyte response in insulin-dependent diabetes mellitus.

Authors:  K G Chandy; A M Charles; A Kershnar; B Buckingham; N Waldeck; S Gupta
Journal:  J Clin Immunol       Date:  1984-11       Impact factor: 8.317

9.  Peripheral T-cell lymphomas. Immunophenotype, lymphokine production, and immunologic functional characteristics of the lymph-node malignant T cells.

Authors:  S Raziuddin; T Malatani; S al-Sedairy; A H al-Saigh
Journal:  Am J Pathol       Date:  1991-11       Impact factor: 4.307

10.  Role of normal adherent cells in the regulation of the autologous mixed lymphocyte reactions in humans.

Authors:  I Pierri; S Rogna; D Pende; D Viglione; M Scudeletti; A Barabino; F Indiveri
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.